Characterization of Monoclonal Antibodies Against the Human Immunodeficiency Virus (HIV) gag Products and Their Use in Monitoring HIV Isolate Variation

References

1. Alizon M., Wain-Hobson s., Montagnier L., Sonigo P. 1986; Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell 46:63–74
   [Google Scholar]
2. Allan J., Coligan J. E., Barin F., Mclane M. F., Sodroski J. G., Rosen C. A., Haseltine W. A., Lee T. H., Essex M. 1985; Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV III. Science 228:1091–1094
   [Google Scholar]
3. Barre-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Daugeut C., Axler-Blin C., Vezinet-Brun F., Rouzioux C., Rozenbaum W., Montagnier L. 1983; Isolation of a T lymphotropic retrovirus from a patient at risk for AIDS. Science 220:868–871
   [Google Scholar]
4. Benn S., Rutledge R., Folks T., Gold J., Baker L., Mccormick J., Feorino P., Piot P., Quinn T., Martin M. 1985; Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science 230:49–951
   [Google Scholar]
5. Chassagne J., Verrélle P., Dionet C., Clavel F., Barre-Sinoussi F., Chermann J. C., Montagnier L., Gluckman J. C., Klatzman D. 1986; A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. Journal of Immunology 136:1442–1445
   [Google Scholar]
6. Coffin J. M. 1986; Genetic variation in AIDS viruses. Cell 46:1–4
   [Google Scholar]
7. Essex M., Allan J., Kanki P., Mclane M. F., Malone G., Kitchen L., Lee T. H. 1985; Antigens of human T- lymphotropic virus type III/lymphadenopathy-associated virus. Annals of Internal Medicine 103:700–703
   [Google Scholar]
8. Gallo R. C., Salahuddin S. Z., Popovic M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai H. B., White G., Forster p., Markham P. 1984; Frequent detection and isolation of cytopathic retrovirus (HTLV III) from patients with AIDS and at risk for AIDS. Science 224:500–503
   [Google Scholar]
9. Hahn B. H., Gonda M. A., Shaw G. M., Popovic M., Hoxie J. A., Gallo R. C., Wong-Staal F. 1985; Genomic diversity of acquired immune deficiency syndrome virus HTLV III: different viruses exhibit greatest divergence in their envelope genes. Proceedings of the National Academy of Sciences U.S.A.: 824813–4817
   [Google Scholar]
10. Hahn B. H., Shaw G. M., Taylor M. E., Redfield R. R., Markham P. D., Salahuddin S. Z., Wong-Staal F., Gallo R. c., Parks E. S., Parks w. p. 1986; Genetic variation in HTLV III/LAV over time in patients with AIDS or at risk for AIDS. Science 232:1548–1553
    [Google Scholar]
11. Montagnier L. 1985; Lymphadenopathy-associated virus: from molecular biology to pathogenicity. Annals of Internal Medicine 103:689–693
    [Google Scholar]
12. Montagnier L., Gruest J., Chamaret S., Dauguet C., Axler C., Guetard D, Barre-Sinoussi F., Chermann J. c., Brunet J. B., Klatzmann D., Gluckman J. C. 1984; Adaption of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science 225:63–66
    [Google Scholar]
13. Pinching A., Weiss R. A. 1986; AIDS and the spectrum of HTLV-III/LAV infection. International Review of Experimental Pathology 28:647–666
    [Google Scholar]
14. Ratner L., Haseltine W., Patarca R., Livak K. J., Starcich B., Josephs S, Doran E. R., Rafalski J. A., Whitehorn E. A., Baumeister K., Ivanoff L., Petteway S. R., Pearson M. L., Lautenberger J. A., Papas T. s., Ghrayeb J., Chang N. T., Gallo R. c., Wong-Staal F. 1985; Complete nucleotide sequence of the AIDS virus, HTLV III. Nature; London: 313277–283
    [Google Scholar]
15. Robey w. G., Safai B, Oroszlan S. 1985; Characterization of envelope and core structural gene products of HTLV III with sera from AIDS patients. Science 228:593–595
    [Google Scholar]
16. Safai B., Sarngadharan M. G., Groopman J. E., Arnett K., Popovic M. J., Sliski A., Schupbach J., Gallo R. C. 1984; Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet i:1438–1440
    [Google Scholar]
17. Salacinski P., Hope J., Mcclean C., Clement-Jones V., Sykes J., Price J., Lowry P. J. 1979; A new simple method which allows theoretical incorporation of radioiodine into proteins and peptides without damage. Journal of Endocrinology 81:131–137
    [Google Scholar]
18. Sanchez-Pescador R., Power M. D., Barr P. J., Steimer K. S., Stempein M. M., Brown-Shimer S. L., Gee W. W., Renard A., Randolph A., Levy J. A., Dina D., Luciw p. A. 1985; Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 111:484–492
    [Google Scholar]
19. Sarngadharan M. G., Popovic M., Bruch L., Schupbach J., Gallo R. c. 1984; Antibodies reactive with human T-lymphotropic retroviruses (HTLV III) in the serum of patients with AIDS. Science 224:506–508
    [Google Scholar]
20. Schupbach J., Popovic M., Gilden R. V., Gonda M. A., Sarngadharan M. G., Gallo R. C. 1984; Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV III) associated with AIDS. Science 224:503–505
    [Google Scholar]
21. Starcich B. R., Hahn B. H., Shaw G. M., Mcneely P.D.M., Drow S., Wolff H., Parks W.P, Gallo R. C. 1986; Identification and characterization of conserved and variable regions in the envelope gene of HTLV III/LAV, the retrovirus of AIDS. Cell 45:637–648
    [Google Scholar]
22. Tedder R. S., Yao J. L., Anderson M. J. 1982; The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgM. Journal of Hygiene 88:335–350
    [Google Scholar]
23. Veronese F.D.M., Sarngadharan M. G., Rahman R., Markham P. D., Popovic M., Bodner A. J., Gallo R. C. 1985; Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III. Proceedings of the National Academy of Sciences U.S.A.: 825199–5202
    [Google Scholar]
24. Wain-Hobson s., Sonigo p., Danos o., Cole s., Alizon M. 1985; Nucleotide sequence of the AIDS virus, LAV. Cell 40:9–17
    [Google Scholar]
25. Webster A.B.D., Malkovsky M., Patterson S., North M., Dalgleish A. G., Beattie R., Asherson G. L., Weiss R. A. 1986; Isolation of retroviruses from two patients with ‘common variable’ hypogammaglobulinemia. Lancet i:581–583
    [Google Scholar]
26. Weiss R. A., Clapham P. R., Cheingsong-Popov R., Dalgleish A. G., Carne C., Weller I.V.D. 1985; Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS risk patients. Nature; London: 31669–72
    [Google Scholar]
27. Weiss R. A., Clapham P. R., Weber J. N., Dalgleish A. G., Lasky L. A., Berman P. W. 1986; Variable and conserved neutralization antigens of human immunodeficiency virus (HIV-1). Nature; London: 324572–575
    [Google Scholar]